Several Canadian [21,22,23,26,27,28,29,30,31,32,33,34] and international studies [17,18,19,20,35,36,37,38] have reported melanoma treatment patterns and outcomes, but these studies have been limited in their reporting on multiple lines of therapy or on BRAF mutation status. The gene discussed is BRAF; the disease is melanoma.